Improved Systems Access Pharmaceuticals Andservices
Total Page:16
File Type:pdf, Size:1020Kb
Systems for Improved Access toPharmaceuticals and Services Improved Access. Improved Services. Better Health Outcomes. Annual Report: Program Year 3 October 2013–September 2014 Cover Photo Credit: Warren Zelman 2 This report is made possible by the generous support of the American people through the US Agency for International Development (USAID), under the terms of cooperative agreement number AID-OAA-A-11-00021. The contents are the responsibility of Management Sciences for Health and do not necessarily reflect the views of USAID or the United States Government. About SIAPS The goal of the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program is to assure the availability of quality pharmaceutical products and effective pharmaceutical services to achieve desired health outcomes. Toward this end, the SIAPS result areas include improving governance, building capacity for pharmaceutical management and services, addressing information needed for decision-making in the pharmaceutical sector, strengthening financing strategies and mechanisms to improve access to medicines, and increasing quality pharmaceutical services. Recommended Citation This report may be reproduced if credit is given to SIAPS. Please use the following citation. Systems for Improved Access to Pharmaceuticals and Services. 2014. Systems for Improved Access to Pharmaceutical Services Annual Report: Project Year 3, October 2013–September 2014. Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Systems for Improved Access to Pharmaceuticals and Services Center for Pharmaceutical Management Management Sciences for Health 4301 North Fairfax Drive, Suite 400 Arlington, VA 22203 USA Telephone: 703.524.6575 Fax: 703.524.7898 E-mail: [email protected] Website: www.siapsprogram.org 3 4 CONTENTS Acronyms and Abbreviations ...............................................................................7 Introduction ...........................................................................................................9 Health Areas ........................................................................................................13 HIV and AIDS .......................................................................................................14 Malaria ..................................................................................................................19 Maternal, Newborn, and Child Health ..................................................................22 Neglected Tropical Diseases .................................................................................26 Tuberculosis ..........................................................................................................28 Intermediate Results ...........................................................................................33 Pharmaceutical Sector Governance Strengthened ...............................................34 Case Study ...................................................................................................... 41 Capacity for Pharmaceutical Supply Management and Services Increased and Enhanced ...............................................................................................................43 Case Study ...................................................................................................... 47 Information for Decision Making Challenges Addressed in the Pharmaceutical Sector ....................................................................................................................50 Case Study ...................................................................................................... 55 Financing Strategies and Mechanisms Strengthened to Improve Access to Medicines ..............................................................................................................57 Case Study ...................................................................................................... 61 Supply Management Improved to Achieve Desired Health Outcomes ................63 Pharmaceutical Services Improved to Achieve Desired Health Outcomes ..........68 Case Study ...................................................................................................... 76 5 Success Stories .....................................................................................................79 Better Patient Data, Better Supply Chain, Better Treatment Outcomes ......... 80 Saving Lives through Improved Access to Contraceptives ............................ 82 A Phone Call for Health: Improving Patient Care and Adherence to Treatment ......................................................................................................................... 85 Investing in Frontline Health Workers: a Better Supply Chain for TB Medicines ........................................................................................................ 88 Improving Health Outcomes: Managing Information to Maximize Resources .. ......................................................................................................................... 90 Forecasting for Family Planning: Getting Procurement Right ....................... 92 Countries ..............................................................................................................95 Angola ............................................................................................................. 96 Bangladesh ...................................................................................................... 99 Burundi ......................................................................................................... 102 Cameroon ...................................................................................................... 104 Dominican Republic ..................................................................................... 106 Democratic Republic of the Congo ............................................................... 108 Ethiopia ......................................................................................................... 111 East, Central, and Southern Africa ................................................................ 116 Guinea ........................................................................................................... 118 LAC Amazon Malaria Initiative ................................................................... 121 Lesotho .......................................................................................................... 123 Mali ............................................................................................................... 125 Mozambique ................................................................................................. 127 Namibia ......................................................................................................... 129 Philippines..................................................................................................... 132 South Africa .................................................................................................. 135 South Sudan .................................................................................................. 140 Swaziland ...................................................................................................... 143 Tajikistan ....................................................................................................... 146 Turkmenistan ................................................................................................ 148 Ukraine .......................................................................................................... 149 Uzbekistan ..................................................................................................... 152 West Africa Regional .................................................................................... 154 Key Lessons in Pharmaceutical Systems Strengthening ...............................157 Financial Information .......................................................................................162 Annexes ..............................................................................................................167 6 ACRONYMS AND ABBREVIATIONS ACPE Accreditation Council for Pharmacy Education ACT artemisinin-based combination therapy ADE adverse drug event AMR antimicrobial resistance APTS Auditable Pharmacy Transactions and Services ART antiretroviral treatment ARV antiretroviral CCM community case management CHW community health worker CPD country project director DGFP Directorate General Family Planning DGHS Directorate General Health Services DOT directly observed treatment DTC Drug and Therapeutic Committee EML Essential Medicine List ECSA East, Central, and Southern Africa [region] EUV end use verification EWS early warning system FDA US Food and Drug Administration Food, Medicine and Health Care Administration and Control FMHACA Authority FP family planning GDF Global Drug Facility Global Fund Global Fund for AIDS, Tuberculosis and Malaria GHI Global Health Initiative HMIS Health Management Information System IPTp Intermittent Prevention Treatment during Pregnancy LCP Lung Center of the Philippines LFA local fund agent LLITN long-lasting insecticide treated net LMIS Logistics Management Information System M&E monitoring and evaluation